Guo‐wen Xing

3.0k total citations · 1 hit paper
91 papers, 2.5k citations indexed

About

Guo‐wen Xing is a scholar working on Molecular Biology, Materials Chemistry and Spectroscopy. According to data from OpenAlex, Guo‐wen Xing has authored 91 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 42 papers in Materials Chemistry and 34 papers in Spectroscopy. Recurrent topics in Guo‐wen Xing's work include Luminescence and Fluorescent Materials (34 papers), Molecular Sensors and Ion Detection (32 papers) and Carbohydrate Chemistry and Synthesis (19 papers). Guo‐wen Xing is often cited by papers focused on Luminescence and Fluorescent Materials (34 papers), Molecular Sensors and Ion Detection (32 papers) and Carbohydrate Chemistry and Synthesis (19 papers). Guo‐wen Xing collaborates with scholars based in China, United States and Hong Kong. Guo‐wen Xing's co-authors include Michael A. Poles, David D. Ho, Moriya Tsuji, Chi‐Huey Wong, Douglass Wu, Guang‐jian Liu, Yuki Kinjo, Mitchell Kronenberg, Gisen Kim and Kazuyoshi Kawahara and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Angewandte Chemie International Edition.

In The Last Decade

Guo‐wen Xing

90 papers receiving 2.4k citations

Hit Papers

Recognition of bacterial glycosphingolipids by natural ki... 2005 2026 2012 2019 2005 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guo‐wen Xing China 24 878 873 590 477 436 91 2.5k
Shoufa Han China 27 482 0.5× 1.3k 1.5× 740 1.3× 480 1.0× 938 2.2× 78 2.7k
S. Kamitori Japan 33 216 0.2× 1.5k 1.7× 602 1.0× 642 1.3× 215 0.5× 120 3.1k
Xinfu Zhang China 37 421 0.5× 1.6k 1.8× 1.4k 2.4× 264 0.6× 1.0k 2.3× 84 3.8k
Irene M. Mavridis Greece 27 166 0.2× 644 0.7× 1.0k 1.8× 798 1.7× 415 1.0× 82 2.5k
Liang He China 31 297 0.3× 1.1k 1.2× 958 1.6× 790 1.7× 229 0.5× 82 3.2k
Xiaohui Liu China 29 165 0.2× 1.3k 1.4× 600 1.0× 151 0.3× 406 0.9× 80 2.6k
Zheng Liu China 26 404 0.5× 773 0.9× 325 0.6× 463 1.0× 51 0.1× 96 2.0k
Amy Barrios United States 25 260 0.3× 956 1.1× 285 0.5× 487 1.0× 186 0.4× 61 2.1k
Kenneth Chan Canada 26 162 0.2× 668 0.8× 842 1.4× 747 1.6× 478 1.1× 43 2.3k

Countries citing papers authored by Guo‐wen Xing

Since Specialization
Citations

This map shows the geographic impact of Guo‐wen Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo‐wen Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo‐wen Xing more than expected).

Fields of papers citing papers by Guo‐wen Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guo‐wen Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo‐wen Xing. The network helps show where Guo‐wen Xing may publish in the future.

Co-authorship network of co-authors of Guo‐wen Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Guo‐wen Xing. A scholar is included among the top collaborators of Guo‐wen Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guo‐wen Xing. Guo‐wen Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yichen, Jialong Jie, Wei Zhou, et al.. (2025). Hepatoma Metastasis‐Inhibiting Supramolecular Nanoglycocalyx for Enhanced Type I Photodynamic Therapy. Advanced Healthcare Materials. 14(9). e2404253–e2404253. 5 indexed citations
3.
Zhang, Jiawei, Xin Niu, Yichen Liu, et al.. (2025). Glycosylated and rhodamine-conjugated tetraphenylethylene: a type I and II reactive oxygen species generator for photodynamic therapy. Chemical Communications. 61(16). 3403–3406. 2 indexed citations
4.
Zhou, Wei, Yichen Liu, Qingyu Ma, et al.. (2023). AIE-active lysosome-targeted fluorescent organic nanoparticles for leucine aminopeptidase-activatable fluorescent imaging and precision photodynamic therapy potential. Dyes and Pigments. 221. 111781–111781. 9 indexed citations
5.
Xing, Guo‐wen, et al.. (2023). New Fluorophore and Its Applications in Visualizing Polystyrene Nanoplastics in Bean Sprouts and HeLa Cells. Molecules. 28(20). 7102–7102. 3 indexed citations
7.
Liu, Guang‐jian, Yuan Zhang, Lingyun Zhou, et al.. (2019). A water-soluble AIE-active polyvalent glycocluster: design, synthesis and studies on carbohydrate–lectin interactions for visualization of Siglec distributions in living cell membranes. Chemical Communications. 55(66). 9869–9872. 11 indexed citations
8.
Shen, Qingya, Hongwei Tan, Guo‐wen Xing, Jimin Zheng, & Zongchao Jia. (2017). A new method to investigate the catalytic mechanism of YhdE pyrophosphatase by using a pyrophosphate fluorescence probe. Scientific Reports. 7(1). 8169–8169. 5 indexed citations
10.
Zhang, Xiaotai, et al.. (2013). Highly efficient α-C-sialylation promoted by (p-Tol)2SO/Tf2O with N-acetyl-5-N,4-O-oxazolidione protected thiosialoside as donor. Organic & Biomolecular Chemistry. 11(30). 5017–5017. 17 indexed citations
11.
Xiang, Yangfei, et al.. (2012). Anti-herpes simplex virus efficacies of 2-aminobenzamide derivatives as novel HSP90 inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(14). 4703–4706. 32 indexed citations
12.
Ju, Huai‐Qiang, Yangfei Xiang, Ying Pei, et al.. (2011). Synthesis and in vitro anti-HSV-1 activity of a novel Hsp90 inhibitor BJ-B11. Bioorganic & Medicinal Chemistry Letters. 21(6). 1675–1677. 31 indexed citations
13.
Ju, Huai‐Qiang, Shaoxiang Wang, Yangfei Xiang, et al.. (2011). BJ-B11, a novel Hsp90 inhibitor, induces apoptosis in human chronic myeloid leukemia K562 cells through the mitochondria-dependent pathway. European Journal of Pharmacology. 666(1-3). 26–34. 20 indexed citations
14.
Liu, Kaisheng, Hui Liu, Qiuyun Liu, et al.. (2011). SNX-2112, an Hsp90 inhibitor, induces apoptosis and autophagy via degradation of Hsp90 client proteins in human melanoma A-375 cells. Cancer Letters. 318(2). 180–188. 48 indexed citations
15.
Wang, Yajuan, et al.. (2010). Assembly of Anionic Conjugated Polymer with 6‐O‐Modified PNP‐β‐Galactoside for Fluorescence Logic‐signal‐based Multiplex Detections of Enzymes. Macromolecular Rapid Communications. 31(16). 1473–1478. 8 indexed citations
16.
Si, Shu‐Feng, et al.. (2010). Protease Immobilization on γ‐Fe2O3/Fe3O4 Magnetic Nanoparticles for the Synthesis of Oligopeptides in Organic Solvents. Chemistry - An Asian Journal. 5(6). 1389–1394. 36 indexed citations
17.
Liu, Zhong, Yong Luo, Mingfeng Xia, et al.. (2010). Preclinical pharmacokinetic analysis of SNX-2112, a novel Hsp90 inhibitor, in rats. Biomedicine & Pharmacotherapy. 65(2). 132–136. 7 indexed citations
18.
Xing, Guo‐wen, Douglass Wu, Michael A. Poles, et al.. (2005). Synthesis and human NKT cell stimulating properties of 3-O-sulfo-α/β-galactosylceramides. Bioorganic & Medicinal Chemistry. 13(8). 2907–2916. 43 indexed citations
19.
Kinjo, Yuki, Douglass Wu, Gisen Kim, et al.. (2005). Recognition of bacterial glycosphingolipids by natural killer T cells. Nature. 434(7032). 520–525. 742 indexed citations breakdown →
20.
Xing, Guo‐wen, et al.. (1998). Influence of reaction conditions on syntheses of sweetener precursors catalyzed by thermolysin in tert‐amyl alcohol. Journal of Peptide Research. 52(4). 300–304. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026